Results
|
6261.
|
|
|
6262.
|
Biweekly doxorubicin/ketoconazole as second-line treatment in docetaxel-resistant, hormone-refractory prostate cancer. [electronic resource] by
- Lainakis, George
- Nikos, Antoniou
- Gerassimos, Alivizatos
- Michael, Chrisofos
- Iraklis, Mitsoyiannis
- Konstantinos, Livadas
- Ioannis, Varkarakis
- Harilaos, Katsifotis
- Dimopoulos, Meletios A
- Bamias, Aristotelis
Producer: 20080729
In:
Urology vol. 71
Availability: No items available.
|
|
6263.
|
Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer. [electronic resource] by
- Kijima, Toshiki
- Fujii, Yasuhisa
- Yokoyama, Minato
- Ishioka, Junichiro
- Matsuoka, Yoh
- Numao, Noboru
- Saito, Kazutaka
- Koga, Fumitaka
- Masuda, Hitoshi
- Kawakami, Satoru
- Kihara, Kazunori
Producer: 20121207
In:
BJU international vol. 110
Availability: No items available.
|
|
6264.
|
|
|
6265.
|
Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer. [electronic resource] by
- Kucukzeybek, Yuksel
- Dirican, Ahmet
- Erten, Cigdem
- Somali, Isil
- Can, Alper
- Demir, Lutfiye
- Bayoglu, Ibrahim Vedat
- Akyol, Murat
- Medeni, Murat
- Tarhan, Mustafa Oktay
Producer: 20130227
In:
Asian Pacific journal of cancer prevention : APJCP vol. 13
Availability: No items available.
|
|
6266.
|
[Early prediction of treatment response by serum CRP levels in patients with advanced esophageal cancer who underwent definitive chemoradiotherapy]. [electronic resource] by
- Yoneda, Masayuki
- Fujiwara, Hitoshi
- Okamura, Shinichi
- Okamura, Hiroko
- Umehara, Seiji
- Todo, Momoko
- Furutani, Akinobu
- Shiozaki, Atsushi
- Komatsu, Shuhei
- Ichikawa, Daisuke
- Okamoto, Kazuma
- Kuriu, Yoshiaki
- Ikoma, Hisashi
- Nakanishi, Masayoshi
- Ochiai, Toshiya
- Kokuba, Yukihito
- Sonoyama, Teruhisa
- Otsuji, Eigo
Producer: 20110217
In:
Gan to kagaku ryoho. Cancer & chemotherapy vol. 37
Availability: No items available.
|
|
6267.
|
|
|
6268.
|
Extended benefit from sequential administration of docetaxel after standard fluorouracil, epirubicin, and cyclophosphamide regimen for node-positive breast cancer: the 8-year follow-up results of the UNICANCER-PACS01 trial. [electronic resource] by
- Coudert, Bruno
- Asselain, Bernard
- Campone, Mario
- Spielmann, Marc
- Machiels, Jean-Pascal
- Pénault-Llorca, Frédérique
- Serin, Daniel
- Lévy, Christelle
- Romieu, Gilles
- Canon, Jean-Luc
- Orfeuvre, Hubert
- Piot, Gilles
- Petit, Thierry
- Jerusalem, Guy
- Audhuy, Bruno
- Veyret, Corinne
- Beauduin, Marc
- Eymard, Jean-Christophe
- Martin, Anne-Laure
- Roché, Henri
Producer: 20130207
In:
The oncologist vol. 17
Availability: No items available.
|
|
6269.
|
Impact of docetaxel in addition to cisplatin and fluorouracil as neoadjuvant treatment for resectable stage III or T3 esophageal cancer: a propensity score-matched analysis. [electronic resource] by
- Nomura, Motoo
- Oze, Isao
- Abe, Tetsuya
- Komori, Azusa
- Narita, Yukiya
- Masuishi, Toshiki
- Taniguchi, Hiroya
- Kadowaki, Shigenori
- Ura, Takashi
- Andoh, Masashi
- Kawai, Ryosuke
- Uemura, Norihisa
- Ishihara, Makoto
- Tanaka, Tsutomu
- Tajika, Masahiro
- Niwa, Yasumasa
- Muro, Kei
- Muto, Manabu
Producer: 20151013
In:
Cancer chemotherapy and pharmacology vol. 76
Availability: No items available.
|
|
6270.
|
|
|
6271.
|
|
|
6272.
|
|
|
6273.
|
|
|
6274.
|
An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumors. [electronic resource] by
- Jotte, Robert M
- Von Hoff, Daniel D
- Braiteh, Fadi
- Becerra, Carlos R
- Richards, Donald A
- Smith, David A
- Garbo, Lawrence
- Stephenson, Joe
- Conkling, Paul R
- Robert-Vizcarrondo, Francisco
- Chen, Jian
- Turner, P Kellie
- Chow, Kay Hoong
- Tai, D Fritz
- Ilaria, Robert
Producer: 20150918
In:
Investigational new drugs vol. 33
Availability: No items available.
|
|
6275.
|
|
|
6276.
|
|
|
6277.
|
Toxicity and quality of life of Korean breast cancer patients treated with docetaxel-containing chemotherapy without primary G-CSF prophylaxis. [electronic resource] by
- Lee, Jihyoun
- Ahn, Min Hye
- Jang, Yun Hee
- Lee, Eun Ju
- Park, Ji Hye
- Rho, Jungho
- Kim, Zisun
- Kim, Hyuk Mun
- Han, Sun Wook
- Lim, Cheolwan
- Lee, Min Hyuk
- Kim, Sung Yong
Producer: 20150702
In:
Breast cancer (Tokyo, Japan) vol. 21
Availability: No items available.
|
|
6278.
|
Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809. [electronic resource] by
- Niho, S
- Ikeda, N
- Michimae, H
- Suzuki, K
- Sakai, H
- Kaburagi, T
- Minato, K
- Kato, T
- Okamoto, H
- Seto, T
- Hosomi, Y
- Shimizu, K
- Oshita, F
- Kunitoh, H
- Tsuboi, M
- Takeuchi, M
- Watanabe, K
Producer: 20131125
In:
British journal of cancer vol. 109
Availability: No items available.
|
|
6279.
|
Retrospective analysis of adjuvant chemotherapy for curatively resected gastric cancer. [electronic resource] by
- Deng, Wei
- Wang, Qi-Wei
- Zhang, Xiao-Tian
- Lu, Ming
- Li, Jie
- Li, Yan
- Gong, Ji-Fang
- Zhou, Jun
- Lu, Zhi-Hao
- Shen, Lin
Producer: 20150413
In:
World journal of gastroenterology vol. 20
Availability: No items available.
|
|
6280.
|
|